Pharma
Regulatory
Glenmark’s Combination Therapy of Remogliflozin Etabonate + Metformin Hydrochloride Receive
Shots: Glenmark has received the regulatory approval to commercialize the combination therapy of remogliflozin etabonate (100mg) + metformin hydrochloride (500/1000mg) as an adjunct to diet and exercise to improve glycemic […]readmore
